Okuyama Ayako, Kuwabara Mai, Zenda Sadamoto
Graduate School of Nursing Science, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, 104-0044, Tokyo, Japan.
Department of Supportive and Palliative Care Research Support Office, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
BMC Cancer. 2025 Jan 20;25(1):103. doi: 10.1186/s12885-025-13519-z.
Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.
A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare.
Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.
The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment.
患者在将治疗与日常生活相结合方面需要得到支持。然而，与治疗相关副作用的支持性护理指标的测量报告不足。本综述旨在确定一份针对成年癌症患者管理癌症治疗引起的毒性的质量指标清单。
于2013年9月26日至2023年12月26日在PubMed、护理及相关健康文献累积索引、Cochrane系统评价数据库和Embase上进行了一项综述。选择已发表的英文文章，这些文章制定或分析了针对成年癌症患者管理癌症治疗引起的毒性的质量指标。根据多纳贝迪安的医疗保健质量模型对确定的指标进行分类。
在18篇文章中确定了42项指标（4项结构指标、27项过程指标和11项结果指标）。8篇文章（44.4%）来自北美，4篇（22.2%）来自欧洲，2篇（11.1%）来自大洋洲，2篇（11.1%）来自亚洲，1篇（5.6%）来自非洲；64.3%的指标是基于指南的过程指标。使用患者报告结局测量确定的患者症状患病率被提议作为一项结果指标。在7项研究（38.9%）中，这些指标是由多学科专家选择的。没有一项研究让患者或家庭成员参与指标选择过程。
应通过测量这些指标来提高支持性护理的质量，考虑到每家医院患者对支持性护理的需求，以便患者在接受治疗的同时能够继续生活。
